International audienceBACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD) are at risk for developing invasive pulmonary aspergillosis. A clinical algorithm has been validated to discriminate colonization from putative invasive pulmonary aspergillosis (PIPA) in Aspergillus-positive respiratory tract cultures of critically ill patients. We focused on critically ill patients with COPD who met the criteria for PIPA.METHODS: This matched cohort study included critically ill patients with COPD from two university hospital intensive care units (ICUs). We studied the risk factors for PIPA as well as the impact of PIPA on short- and long-term outcomes. Whether PIPA was associated with a pattern of bacterial colonization a...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
The reported incidence of COVID-19-associated pulmonary aspergillosis (CAPA) ranges between 2.4% and...
International audienceBACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD...
International audienceBACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD...
International audienceIntroduction: Patients with advanced chronic obstructive pulmonary disease (CO...
Nowadays, reports in the literature support that patients with severe chronic obstructive pulmonary ...
Nowadays, reports in the literature support that patients with severe chronic obstructive pulmonary ...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
Information on invasive aspergillosis (IA) and other invasive filamentous fungal infections is limit...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
SUMMARY Invasive pulmonary aspergillosis (IPA) is an infection rarely seen in intensive care units...
Fungal infections have become a common threat in Intensive Care Units (ICU). The epidemiology of inv...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
The reported incidence of COVID-19-associated pulmonary aspergillosis (CAPA) ranges between 2.4% and...
International audienceBACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD...
International audienceBACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD...
International audienceIntroduction: Patients with advanced chronic obstructive pulmonary disease (CO...
Nowadays, reports in the literature support that patients with severe chronic obstructive pulmonary ...
Nowadays, reports in the literature support that patients with severe chronic obstructive pulmonary ...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
Information on invasive aspergillosis (IA) and other invasive filamentous fungal infections is limit...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
SUMMARY Invasive pulmonary aspergillosis (IPA) is an infection rarely seen in intensive care units...
Fungal infections have become a common threat in Intensive Care Units (ICU). The epidemiology of inv...
Invasive pulmonary aspergillosis (IPA) is an increasingly recognised problem in critically ill patie...
BACKGROUND: In this study we evaluated the incidence of invasive pulmonary aspergillosis among intub...
The reported incidence of COVID-19-associated pulmonary aspergillosis (CAPA) ranges between 2.4% and...